Chaffin Joanna M, Savage Natasha M, Sharma Suash, Bryan Locke J, Raffeld Mark, Jaffe Elaine S
Department of Pathology, Medical College of Georgia, Augusta University, 1120, 15th Street, Augusta, GA 30912, United States.
Department of Hematology/Oncology, Medical College of Georgia, Augusta University, 1120, 15th Street, Augusta, GA, 30912, United States.
Hum Pathol (N Y). 2017 Nov;10:74-78. doi: 10.1016/j.ehpc.2017.06.006. Epub 2017 Jul 9.
Marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is associated with chronic inflammatory disorders. We present an indolent pancolonic MALT lymphoma occurring in a 39-year-old female with history of autoimmune hepatitis requiring liver transplant in 1997 and ulcerative colitis diagnosed in 2004. Random biopsies from a grossly unremarkable surveillance colonoscopy in 2015 revealed a dense monomorphic plasmacytoid infiltrate causing expansion of lamina propria without significant crypt infiltration or destruction. These cells were positive for CD79a and CD138 and showed lambda restriction; however, CD20, CD43, CD56, HHV8, and EBER were negative. A similar pancolonic infiltrate was identified in all prior colorectal biopsies from 2010 and 2012 upon retrospective review. Subsequent computed tomography of the abdomen revealed no bowel wall thickening nor enlarged lymph nodes. Bone marrow revealed involvement consistent with stage IV disease. Biopsies from 2010 and 2015 demonstrated clonal immunoglobulin gene rearrangement. mutation was not detected. The overall features were indicative of MALT lymphoma. Although low-grade B-cell lymphomas are not considered part of the post-transplant lymphoproliferative disorder spectrum, such cases have been reported, and are typically EBV-negative. Patient underwent treatment with pentostatin for her MALT lymphoma reaching a sustained remission despite additional immunosuppression for resurgent hepatic dysfunction. To our knowledge, this is the first reported case of EBV-negative pancolonic MALT lymphoma with plasmacytic differentiation post liver transplant presenting in an indolent, asymptomatic fashion with persistence for greater than five years successfully managed without compromising the patient's liver transplant.
黏膜相关淋巴组织边缘区淋巴瘤(MALT淋巴瘤)与慢性炎症性疾病相关。我们报告了一例发生在一名39岁女性的惰性全结肠MALT淋巴瘤,该女性有自身免疫性肝炎病史,于1997年需要进行肝移植,并于2004年被诊断为溃疡性结肠炎。2015年,在一次大体无异常的结肠镜监测检查中进行的随机活检显示,有密集的单形性浆细胞样浸润,导致固有层扩张,无明显隐窝浸润或破坏。这些细胞CD79a和CD138呈阳性,显示λ限制性;然而,CD20、CD43、CD56、HHV8和EBER均为阴性。回顾性审查发现,2010年和2012年之前所有的结直肠活检中均发现了类似的全结肠浸润。随后的腹部计算机断层扫描显示没有肠壁增厚,也没有肿大的淋巴结。骨髓检查显示符合IV期疾病。2010年和2015年的活检显示克隆性免疫球蛋白基因重排。未检测到突变。总体特征提示为MALT淋巴瘤。虽然低级别B细胞淋巴瘤不被认为是移植后淋巴增殖性疾病谱的一部分,但此类病例已有报道,且通常为EBV阴性。尽管因复发性肝功能障碍需要额外的免疫抑制,但该患者接受了喷司他丁治疗其MALT淋巴瘤,达到了持续缓解。据我们所知,这是首例报告的肝移植后出现的EBV阴性、具有浆细胞分化的全结肠MALT淋巴瘤,以惰性、无症状的方式持续存在超过五年,在不影响患者肝移植的情况下成功得到治疗。